Studies targeting lung cancer, liver cancer, and pancreatic cancer have all confirmed that TUBA1C promotes tumorigenesis and progression and is a potential prognostic biomarker for liver cancer and pancreatic cancer. Here, TUBA1C is linked to pancreatic neoplasm.